These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19359152)

  • 21. Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations.
    Butler AE; Abouseif A; Dargham SR; Sathyapalan T; Atkin SL
    Sci Rep; 2020 Nov; 10(1):18895. PubMed ID: 33144665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of obesity on androstenedione to testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia.
    Misichronis G; Georgopoulos NA; Marioli DJ; Armeni AK; Katsikis I; Piouka AD; Saltamavros AD; Roupas ND; Panidis D
    Gynecol Endocrinol; 2012 Apr; 28(4):249-52. PubMed ID: 21970600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.
    Weerakiet S; Bunnag P; Phakdeekitcharoen B; Wansumrith S; Chanprasertyothin S; Jultanmas R; Thakkinstian A
    Gynecol Endocrinol; 2007 Mar; 23(3):153-60. PubMed ID: 17454169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome.
    Cho LW; Sathyapalan T; Kilpatrick ES; Keevil BG; Miller AG; Coady AM; Ahmed L; Atkin SL
    BMC Endocr Disord; 2017 May; 17(1):26. PubMed ID: 28525998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
    Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
    Güneş M; Bukan N
    Gynecol Endocrinol; 2015; 31(11):903-6. PubMed ID: 26291814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
    Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
    Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
    Li L; Feng Q; Ye M; He Y; Yao A; Shi K
    J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
    Sills ES; Drews CD; Perloe M; Tucker MJ; Kaplan CR; Palermo GD
    Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
    Gupta V; Mishra S; Mishra S; Gupta V
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of decreased myonectin levels with metabolic and hormonal disturbance in polycystic ovary syndrome.
    Demir İ; Guler A
    Gynecol Endocrinol; 2020 Nov; 36(11):947-950. PubMed ID: 32314610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.
    Huang R; Zheng J; Li S; Tao T; Ma J; Liu W
    Acta Obstet Gynecol Scand; 2015 May; 94(5):494-500. PubMed ID: 25711494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
    Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.